LEMBO, Serena
 Distribuzione geografica
Continente #
NA - Nord America 7.224
AS - Asia 4.954
EU - Europa 4.334
SA - Sud America 598
Continente sconosciuto - Info sul continente non disponibili 234
AF - Africa 76
OC - Oceania 6
Totale 17.426
Nazione #
US - Stati Uniti d'America 7.093
HK - Hong Kong 2.216
IT - Italia 2.041
FI - Finlandia 1.200
SG - Singapore 1.197
CN - Cina 574
BR - Brasile 445
VN - Vietnam 416
RU - Federazione Russa 249
FR - Francia 145
DE - Germania 123
UA - Ucraina 113
IE - Irlanda 111
KR - Corea 107
SE - Svezia 95
TR - Turchia 92
IN - India 90
AR - Argentina 64
NL - Olanda 55
BD - Bangladesh 54
CA - Canada 54
GB - Regno Unito 47
JP - Giappone 46
MX - Messico 39
AT - Austria 26
EC - Ecuador 24
PL - Polonia 24
CO - Colombia 23
IQ - Iraq 23
ES - Italia 22
ID - Indonesia 21
PK - Pakistan 16
VE - Venezuela 15
ZA - Sudafrica 15
CH - Svizzera 14
MY - Malesia 13
PH - Filippine 13
JM - Giamaica 11
KE - Kenya 10
PY - Paraguay 10
TN - Tunisia 10
UZ - Uzbekistan 10
CZ - Repubblica Ceca 9
EG - Egitto 9
MA - Marocco 9
LT - Lituania 8
DZ - Algeria 7
JO - Giordania 7
PE - Perù 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
BE - Belgio 6
SA - Arabia Saudita 6
GR - Grecia 5
HR - Croazia 5
IL - Israele 5
BG - Bulgaria 4
BH - Bahrain 4
CL - Cile 4
CR - Costa Rica 4
DK - Danimarca 4
ET - Etiopia 4
HN - Honduras 4
OM - Oman 4
PA - Panama 4
PS - Palestinian Territory 4
AL - Albania 3
BN - Brunei Darussalam 3
DO - Repubblica Dominicana 3
GE - Georgia 3
GT - Guatemala 3
IR - Iran 3
KW - Kuwait 3
LU - Lussemburgo 3
NI - Nicaragua 3
PT - Portogallo 3
RO - Romania 3
RS - Serbia 3
SN - Senegal 3
UY - Uruguay 3
AO - Angola 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
HU - Ungheria 2
LB - Libano 2
MK - Macedonia 2
MN - Mongolia 2
MU - Mauritius 2
NP - Nepal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
CU - Cuba 1
CY - Cipro 1
GL - Groenlandia 1
Totale 17.174
Città #
Dallas 2.907
Hong Kong 2.211
Helsinki 1.180
Singapore 566
San Jose 565
Milan 509
Ann Arbor 465
Chandler 339
Princeton 298
Ashburn 236
Rome 231
Woodbridge 207
Council Bluffs 189
Houston 159
Beijing 149
Wilmington 136
The Dalles 122
Ho Chi Minh City 120
Lauterbourg 119
Jacksonville 118
Dublin 107
Moscow 90
Dong Ket 87
Naples 83
Izmir 78
New York 64
Hanoi 62
Santa Clara 62
Los Angeles 56
Salerno 51
Andover 50
Munich 49
Nanjing 46
São Paulo 43
Boardman 40
Pellezzano 39
Tokyo 39
Turin 38
Figino 35
Bari 29
Amsterdam 27
Genoa 25
Nuremberg 25
Seattle 25
Redwood City 24
Stockholm 24
Columbus 23
Hebei 23
Orem 23
Chennai 21
Fairfield 21
Warsaw 21
Bologna 20
Frankfurt am Main 20
Palermo 20
Rio de Janeiro 20
Florence 19
Brooklyn 18
Da Nang 18
Shenyang 18
Denver 17
Fisciano 17
Phoenix 17
Seoul 17
Changsha 16
London 16
Mexico City 16
Montreal 16
San Francisco 16
Haiphong 15
Mumbai 15
Norwalk 15
Curitiba 14
Turku 14
Verona 14
Boston 13
Catania 13
Chicago 12
Pune 12
Messina 11
Napoli 11
Quito 11
Belo Horizonte 10
Cava de' Tirreni 10
Vienna 10
Baghdad 9
Thái Nguyên 9
Toronto 9
Albignasego 8
Atlanta 8
Las Vegas 8
Nanchang 8
Shanghai 8
Taranto 8
Tashkent 8
Venice 8
West Jordan 8
Brasília 7
Brno 7
Buenos Aires 7
Totale 12.877
Nome #
058 Oxidative stress in atopic dermatitis and cardiovascular disease: urinary biopyrrins as possible biomarker 3.990
Eruzione cutanea dopo vaccino SARS CoV-2 in paziente psoriasico trattato con MTX 893
A Long-Term Real-Life Safety Study of Guselkumab in Psoriasis Patients with Infectious Comorbidities, Malignancies or Heart Disease: The EARLY Study 484
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis 442
Automatic psoriasis assessment methods: Current scenario and perspectives from a metrologic point of view 334
Systemic Treatment of Pediatric Psoriasis: A Review 301
Prevalence, Features and Degree of Association of Oral Lesions in COVID-19: A Systematic Review of Systematic Reviews 250
Psoriasi eritrodermica: rapida efficacia di bimekizumab 214
The anti-inflammatory and antioxidant properties of 1,2-decanediol and willow bark extract in lipopolysaccharide-stimulated keratinocytes 175
An acute spondyloarthritis during successful treatment with dupilumab for severe atopic dermatitis 171
Anti-inflammatory properties of low and high doxycycline doses: An in vitro study 165
Psoriasi e salute del cavo orale: un nesso da non sottovalutare. I primi risultati di uno studio clinico osservazionale 153
Farsi promotori di salute: “Safe Sun Coast” 147
Phenolics from Castanea sativa leaves and their effects on UVB-induced damage 144
IL-36 cytokines are increased in acne and hidradenitis suppurativa 144
Sicurezza ed efficacia di Apremilast in paziente psoriasico oncologico in terapia con pembrolizumab 140
AUF-1 and skin inflammation: atopic dermatitis and psoriasis 133
Psoriasis and bone damage: the role of phosphodiesterase 4 in the pro-osteoclastogenic process induced by skin inflammation. 132
Photodermatoses 128
Effectiveness and Tolerability of a Patch Containing Onion Extract and Allantoin for Cesarean Section Scars 128
Cannabidiol exerts multitarget immunomodulatory effects on PBMCs from individuals with psoriasis vulgaris 125
Understanding the role of haptoglobin in psoriasis: Effects of ultraviolet B 124
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis 119
The modulatory effect of ellagic acid and rosmarinic acid on ultraviolet-B-induced cytokine/chemokine gene expression in skin keratinocyte (HaCaT) cells 113
Atopic dermatitis: Epidemiology and clinical phenotypes 113
Nicotinamide downregulates gene expression of interleukin-6, interleukin-10, monocyte chemoattractant protein-1, and tumour necrosis factor-α gene expression in HaCaT keratinocytes after ultraviolet B irradiation 112
Milk thistle and olive extract: old substances with a new mission against sun-induced skin damage 112
Presence of BAG3 protein in serum samples from patients affected by psoriasis 111
Anti-tumor necrosis factor-α therapy in the management of psoriasis and B-chronic lymphocytic leukemia 111
Photosensitivity and cancer immune-targeted therapies 109
Interleukin-33: increasing role in dermatological conditions 109
Understanding Barriers Impacting upon Patient Wellbeing: A Nationwide Italian Survey and Expert Opinion of Dermatologists Treating Patients with Moderate-to-Severe Psoriasis 107
Fotodermatosi 107
Anti-IL-17 therapy rapidly decreases osteoclast activity in psoriatic patients: A novel quality in addition to its efficacy and safety 105
Surprise from skin nodules after travel to South America 103
Carcinoma basocellulare con invasione perineurale: gestione terapeutica 102
Confronto del profilo di efficacia, sicurezza e compliance tra Apremilast, NB-UVB e MTX nei pazienti psoriasici: i primi risultati di uno studio osservazionale multicentrico italiano 102
Toilet contact dermatitis 100
Abnormal isoaspartyl residues in erythrocyte membranes from psoriatic patients 99
The effect of visible blue light on the differentiation of dendritic cells in vitro 97
Aberrant gene expression with deficient apoptotic keratinocyte clearance may predispose to polymorphic light eruption 95
A New Light on the Dark DNA Damages 95
A preterm infant with benign neonatal hemangiomatosis and persistent patent ductus arteriosus: A curious comorbidity 95
Polymorphic light eruption and skin cancer prevalence: Is one protective against the other? 94
Un ingrediente fitoattivo da scarti di Castanea sativa 92
Cancrum oris in a boy with Down syndrome 90
Skin cancer overview. Chapter I: Photodermatoses and skin cancer. 90
"Pro-osteoclastogenesis march" is induced by cutaneous pro-inflammatory mediators 89
Oral Lesions and Oral Health-Related Quality of Life in Adult Patients with Psoriasis: A Retrospective Chart Review 88
AUF-1 and skin inflammation: atopic dermatitis and psoriasis 87
121 Oxidative stress in atopic dermatitis: urinary biopyrrins as possible new biomarker 87
Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B 86
Apremilast, NB-UVB e MTX: confronto del profilo di efficacia, di sicurezza e capacità di modulazione dell’infiammazione sistemica nei pazienti psoriasici. Studio osservazionale di coorte prospettico 86
Secukinumab e popolazioni speciali: focus su tubercolosi latente ed epatite virale: studio retrospettivo 86
Risankizumab efficacy and safety in psoriatic patients with latent tuberculosis infection: A multicentric real-world study 85
"Active" photoprotection: Sunscreens with DNA repair enzymes 82
Psoriasiform dermatitis during dupilumab treatment in atopic patient resolved after combo-therapy with methotrexate 81
Paraoxonases and psoriasis: negative imbalance of anti--oxidant endogenous mechanisms 81
IL-33 is regulated by TNF-α in normal and psoriatic skin 80
Cutaneous Eruption after SARS-CoV-2 vaccine in psoriatic patient treated with methotrexate 77
PDE4 Inhibition Reduced Osteoclast Differentiation in Psoriatic Patients 75
Assessing the beneficial impact of a patient support program in secukinumab-treated patients with psoriasis in italy 75
Professional's and non-professional's papular urticaria caused by Scleroderma domesticum 75
Pizza makers' contact dermatitis 75
Hair whitening in a patient with psoriasis during failure of adalimumab treatment reversed by ixekizumab 74
Clinical predictors of psoriatic arthritis and osteoclast differentiation 74
From the skin to the bone: Pro-osteoclastogenesis inflammatory march 74
A severe relapse of pemphigus vulgaris after SARS-CoV-2 vaccination 73
IL-26 in allergic contact dermatitis: Resource in a state of readiness 73
Psoriasis in melanoma patients: a prospective pilot study 72
Effects of adalimumab therapy in adult subjects with moderate-to-severe psoriasis on Th17 pathway 70
Mammalian target of rapamycin in inflammatory skin conditions 68
null 67
Polymorphic light eruption: What's new in pathogenesis and management 66
Predictive Factors for Super Responder Status and Long-Term Effectiveness of Guselkumab in Psoriasis: A Multicenter Retrospective Study 66
null 65
Italian National Registry of Alopecia Areata: an epidemiological study of 699 Italian patients 64
null 64
Contact sensitization of children referred to the Dermatology Department of the University Federico II of Naples, Italy: a two-decade years history 64
The important role of interdisciplinary collaboration in the management of a melanocytic skin lesion 64
null 63
Real-Life Effectiveness and Safety of Guselkumab in Patients with Psoriasis Who Have an Inadequate Response to Ustekinumab: A 3-Year Multicenter Study 62
Farmaci biologici e small molecules in dermatite atopica: confronto su efficacia e sugli effetti nella gestione del prurito 62
Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders 61
null 60
Effectiveness and safety of secukinumab in Italian patients with psoriasis: an 84 week, multicenter, retrospective real-world study 60
Crosstalk between skin inflammation and adipose tissue-derived products: pathogenic evidence linking psoriasis to increased adiposity 59
IL-26: A new actor in allergic contact dermatitis 59
null 58
Disseminated mucocutaneous Candida infection during anti IL-17A therapy in a psoriatic patient 58
Immuno-Pathogenesis of Chronic Inflammatory Skin Diseases: Novel Molecular Targets and Biomarkers 57
Sporotrichosis: long-term treatment and follow-up in a diabetic patient from Southern Italy 57
Crack abuse-induced recalcitrant ulcers 57
Misurazione dinamica degli inquinanti in pazienti affetti da dermatite atopica 56
null 55
Mammalian target of rapamycin, insulin resistance and hidradenitis suppurativa: A possible metabolic loop 55
null 54
Pro-osteoclastogenesis march is enhanced by cutaneous pro-inflammatory mediators 54
Dupilumab therapy reduces urinary biopyrrin levels in atopic patients: a new possible biomarker of oxidative status in atopic dermatitis 53
null 52
Totale 15.144
Categoria #
all - tutte 51.674
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.674


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022483 0 4 3 12 30 5 5 18 56 47 75 228
2022/2023910 89 64 24 114 86 175 6 103 157 15 51 26
2023/2024688 45 80 38 32 48 54 36 44 21 79 61 150
2024/20251.966 95 39 132 157 93 242 229 124 332 120 186 217
2025/202611.103 302 2.108 3.174 449 661 295 922 250 1.448 610 188 696
2026/2027415 273 142 0 0 0 0 0 0 0 0 0 0
Totale 17.426